Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-17 6:40 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.28 | $928,005 | 10,898,669 (Indirect Direct) | View |
| 2024-04-09 Sale | 2024-04-10 5:36 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.2773 | $927,735 | 10,999,622 (Indirect Direct) | View |
| 2024-03-22 Sale | 2024-03-26 6:48 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 97,610 | $9.1212 | $890,322 | 11,048,669 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 9:51 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 2,390 | $9.026 | $21,572 | 11,097,627 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 7:55 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $9.1368 | $913,681 | 11,149,622 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 8:17 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 3,782 | $9.0165 | $34,101 | 9,151,123 (Indirect Direct) | View |
| 2024-02-26 Sale | 2024-02-28 9:04 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 99,478 | $9.0208 | $897,368 | 9,152,123 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 48,260 | $1.44 | 12,900,073 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 130,993 | $0 | 12,900,073 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-24 6:17 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 82,733 | $0.84 | 12,900,073 (Indirect) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 69,444 | $1.44 | 13,018,876 (Direct) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 188,491 | $0 | 13,018,876 (Direct) | View |
| 2024-04-19 Exercise | 2024-04-22 7:22 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 119,047 | $0.84 | 13,018,876 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:53 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 1,180,000 | $0 | 10,952,522 (Direct) | View |
| 2023-05-17 Gift | 2024-01-04 4:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 1,050,000 | $0 | 10,952,522 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:00 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 1,450,000 | $0 | 1,450,000 (Direct) | View |
| 2022-11-08 Option Award | 2022-11-10 6:00 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E President and CEO 10% Owner | 11,914,752 | $0 | 7,587,898 (Direct) | View |